Local and Systemic Management Options for Melanoma Brain Metastases

Cancer J. 2024 Mar-Apr 01;30(2):102-107. doi: 10.1097/PPO.0000000000000711.ABSTRACTDevelopment of brain metastasis is one of the most serious complications of advanced melanoma, carrying a significant burden of morbidity and mortality. Although advances in local treatment modalities such as stereotactic radiosurgery and breakthrough systemic therapies including immunotherapy and targeted therapies have improved the outcomes of patients with metastatic melanoma, management of patients with melanoma brain metastases (MBMs) remains challenging. Notably, patients with MBMs have historically been excluded from clinical trials, limiting insights into their specific treatment responses. Encouragingly, a growing body of evidence shows the potential of systemic therapies to yield durable intracranial responses in these patients, highlighting the need for inclusion of patients with MBMs in future clinical trials. This is pivotal for expediting the advancement of novel therapies tailored to this distinct patient population. In this review, we will highlight the evolving landscape of MBM management, focusing on local and systemic treatment strategies.PMID:38527263 | DOI:10.1097/PPO.0000000000000711
Source: Cancer Journal - Category: Cancer & Oncology Authors: Source Type: research